學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Glenwood Laboratories Canada Ltd.: Coping with Tariff War
內容大綱
In August 2018, Glenwood Laboratories Canada Ltd. (Glenwood), an importer of medical devices from the United States, is caught in the crossfire of public policy. In June 2018, the United States imposed a 10 per cent tariff on the import of raw aluminum from Canada; in July 2018, Canada imposed a retaliatory tariff of 10 per cent on the import of processed aluminum from the United States. As an importer of aluminum oxygen cylinders from the United States for distribution to its Canadian customers, Glenwood is in the middle of a trade war between the two countries, whose aluminum supply chains have been integrated for over two decades. Glenwood's president and chief executive officer (CEO) must examine the options before him and find a way forward.